Welcome to Saint Mary's Health Care Directions Donate Now! SitemapContact UsSearch

CareersFind a PhysicianClinical ServicesPatient ServicesHealth InformationAbout UsNewsHome 
  Join Our Team!
  Diversity at Saint Mary's
 

 
Clinical Services


Overview

About Us

How to Refer Patients

What's New

Treatments

Diseases and Conditions

Contact Us

MD News
Neuroscience

Alzheimer’s Disease and Memory Disorders

Overview
Causes and risk factors
Types
Prevention
Symptoms
Diagnosis
Treatment

Alzheimer’s Disease Overview

Alzheimer’s disease, a form of dementia, is a progressive brain disorder producing impairment of intellectual function. The rate of progression is different for each person. Alzheimer’s disease that develops rapidly is likely to continue to progress rapidly. Conversely, if it has been slow to progress, it will likely continue at a slow rate of progression.

Causes, incidence, and risk factors

The cause of Alzheimer’s disease is not yet known. However, researchers insist that the disease is not a part of normal aging. Theories regarding the presence of aluminum, lead, mercury and other substances in the body have been disproved.

A diagnosis of Alzheimer’s disease is made by the detection of characteristic symptoms, and by the exclusion of other causes of dementia. It can be confirmed by a post-mortem microscopic examination of a sample of brain tissue.

The brain tissue of people with Alzheimer’s disease will show a greater-than-normal incidence of such phenomena as “neurofibrillary tangles” (twisted fragments of protein within nerve cells that clog up the cell), “neuritic plaques” (abnormal clusters of dead and dying nerve cells, other brain cells, and protein), and “senile plaques” (areas where products of dying nerve cells have accumulated around protein).

The destruction of nerve cells, or neurons, leads to a decrease in neurotransmitters – chemicals that are secreted by a neuron to send a message to another neuron. The correct balance of neurotransmitters is essential to the proper functioning of the brain. Three types of neurotransmitters that are commonly affected by Alzheimer’s disease are acetylcholine, serotonin, and norepinephrine.

Researchers theorize that Alzheimer’s disease causes both structural and chemical problems in the brain. The disease seems to disconnect areas of the brain that normally work together.

Types of Alzheimer’s disease

The two types of Alzheimer’s disease are early onset and late onset. In early onset Alzheimer’s disease, symptoms first appear before age 60. Some early onset Alzheimer’s disease runs in families and involves “autosomal dominant” – inherited mutations that may be the cause of the disease. So far, three early onset genes have been identified. Early onset Alzheimer’s disease is the less common form, accounting for about 5 percent of cases.

Late onset Alzheimer’s disease is the more common form. It develops in people 60 and older, and is believed to be less likely to occur in families. In late onset Alzheimer’s disease, the role of genes is not entirely clear. It is believed the genes may not cause the problem itself, but simply increase the likelihood of formation of plaques and tangles or other related pathologies in the brain.

Prevention of Alzheimer’s disease

Today, there is no proven way to prevent the onset of Alzheimer’s disease. A number of investigations are being carried out to understand the role of common medications in the prevention of Alzheimer’s disease. These include non-steroidal anti-inflammatory drugs (NSAIDs), antioxidants (such as Vitamin E), estrogen replacement therapy, and gingko biloba. It should be pointed out that none of these are currently recommended, and all have side effects. And they can all interact with other medications. Consult a physician before considering or taking them.

Symptoms of Alzheimer’s disease

In the early stages, the symptoms of Alzheimer’s disease may be very subtle. Symptoms may include:

  • Repeating statements frequently
  • Frequently misplacing items
  • Trouble finding names for familiar objects
  • Getting lost on familiar routes
  • Personality changes
  • Becoming passive and losing interest in things previously enjoyed

Some tasks that were once routine become difficult at this early stage, such as balancing a checkbook, playing complex games (such as bridge), and learning new and complex information or routines.

In its more advanced stage, the deficits are becoming more obvious. Some of the symptoms are:

  • A decrease in knowledge of recent events
  • Forgetting events in one’s own life
  • Problems choosing clothing items
  • Hallucinations, arguments, striking out, and violent behavior
  • Delusions, depression, agitation

Normal tasks, such as driving, preparing meals and managing finances, are likely to present difficulty to a person at this stage.

[Back to Top]

Diagnostic steps

The first step in diagnosing Alzheimer’s disease is to establish that dementia is present. The second step is to clarify the type of dementia. This is accomplished via a thorough history, a physical exam, neurological exam, and a mental status examination.

Some physicians may order tests to determine if a treatable condition exists which is causing dementia or is exacerbating the onset of Alzheimer’s disease. These conditions include thyroid disease, vitamin deficiency, brain tumor, drug and medication intoxication, chronic infection, and severe depression.

Alzheimer’s disease usually has an identifiable presentation of symptoms, and it can be diagnosed accurately by history and physical exam in 90 to 95 percent of cases. Tests that are typically used include blood tests, computed tomography, magnetic resonance imaging and positron emission tomography (PET scanning).

[Back to Top]

Treatment

The progression of Alzheimer’s disease can be slowed but not stopped. Treatment focuses on:

  • attempting to slow the progression
  • managing the behavior problems, confusion and agitation
  • modifying the home environment
  • supporting the family

In recent years, drug treatment has shown promise in slowing the progression of the disease and potentially improving cognitive function.

Learn more about Saint Mary’s Alzheimer’s Disease and Memory Disorders Program

[Back to Top]

Careers | Contact Us | Sitemap | Home
©2006 Saint Mary's Health Care. All rights reserved.